$7.42
0.202.77%
At close: -
$7.45
0.030.41%
After Hours: Dec 20, 7:29 PM EDT
Comments
Loading...
ITeos Therapeutics (ITOS) Forecast
NewsEarningsITeos Therapeutics (ITOS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestITeos Therapeutics (NASDAQ:ITOS) Stock Quotes, Forecast and News Summary
ITeos Therapeutics Stock (NASDAQ: ITOS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ITeos Therapeutics (ITOS) stock?
You can purchase shares of ITeos Therapeutics (NASDAQ:ITOS) through any online brokerage.
Who are ITeos Therapeutics (ITOS) competitors?
Other companies in ITeos Therapeutics’s space includes: Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT), Larimar Therapeutics (NASDAQ:LRMR), Eledon Pharma (NASDAQ:ELDN) and Anika Therapeutics (NASDAQ:ANIK).
What is the forecast, or price target, for ITeos Therapeutics (ITOS) stock?
ITeos Therapeutics has a consensus price target of $30.83.
What is the current price for ITeos Therapeutics (ITOS)?
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $7.4501 last updated December 20, 2024 at 7:29 PM EST.
Does ITeos Therapeutics (ITOS) pay a dividend?
There are no upcoming dividends for ITeos Therapeutics.
When is ITeos Therapeutics (NASDAQ:ITOS) reporting earnings?
ITeos Therapeutics’s Q4 earnings are confirmed for Wednesday, March 5, 2025.
Is ITeos Therapeutics (ITOS) going to split?
There is no upcoming split for ITeos Therapeutics.
What sector and industry does ITeos Therapeutics (ITOS) operate in?
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.